Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for February 07, 2007 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Rozerem for Sleeping Disorder
New product Rozerem for sleeping disorders has been launched if the USA and had been approved by Food and Drug Administration. 
x-small text small text medium text large text


    /24-7PressRelease/ - BINGHAMTON, NY, February 07, 2007 - New product Rozerem for sleeping disorders has been launched if the USA and had been approved by Food and Drug Administration.

Generally people above 55 age has common problem of difficulty initiating sleep, difficulty maintaining sleep, waking too early in the morning. The study have evaluates Rozerem can reduce sleep problems in people with mild to moderate Alzheimer's disease. Rozerem is approved by the Food and Drug Administration as sleeping aid, but it has not been tested specifically in people with Alzheimer's disease.

The U.S. Food and Drug Administration (FDA) approved the use of Rozerem in July of 2005. prior to FDA approval, Dr Fanny Gomes and her colleagues researched drug side effect, capitalizing on the fact that monkey- just like human can be trained to recognize the specific effects of a drug class says, Dr. Fanny Gomes," those experienced with the 'feeling' of a particular drug can easily recognize when they have received that drug and can reliably detect when they have been given a drug from a different pharmacologic class."

This researched has highlighted significant differences between Rozerem and any other sleeping Aid. The finding also indicates that Rozerem will not produce physical dependence in human. Thus, finding is potentially important for the treatment of sleep problem.

As part of the effort to develop effective behavioral and medical sleep therapies, scientists considering the potential for dependence and abuse associated with prescription sleep drugs. The recent laboratory studies has shown that rozerem drug has no side effect targeting of the brain's melatonin receptors, said Dr. Peter Wan. Rozerem sleeping aid is the highest sleeping drug that has been sold all over the countries.

To get more detail information about Rozerem, please visit http://www.benzer11.com/rozerem.html on web.

About Benzer11.com
Benzer11.com has a team of committed pharmacists who are quite professional for their principals and values and lead a team of branch colleagues within their community.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Olivia Andrews:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Olivia Andrews
www.benzer11.com

Writer
Binghamton, NY
New York, New York
USA 13902
Voice: (607) 722-1734
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.